Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

ALP and LECT2 are markers of SZN-043 target engagement and Wnt pathway activation

Nov. 22, 2021

A-2342: a highly potent, selective, orally available NTCP inhibitor

Nov. 19, 2021

AASLD meeting: Cholangiocytes can induce liver regeneration

Nov. 16, 2021

New HSD17B13 inhibitors identified at Inipharm

Nov. 9, 2021

ADA2-mediated signaling promotes liver fibrosis in NAFLD

Nov. 4, 2021

New HLA-DRB1 ligands identified at Janssen Pharmaceutica

Oct. 26, 2021

Sangamo presents IL23R-CAR-Tregs for treating Crohn's disease

Oct. 26, 2021

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent GLP-1 receptor agonists

Oct. 25, 2021

Uncovering the roles of enteric glial cells in intestinal homeostasis, immunity and tissue repair

Oct. 22, 2021

BenevolentAI nominates preclinical candidate for novel ulcerative colitis target

Oct. 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...